Department of Veterinary Microbiology and Preventive Medicine
Michael Wannemuehler has not added Biography.
If you are Michael Wannemuehler and would like to personalize this page please email our Author Liaison for assistance.
Five-color flow cytometric analysis of swine lymphocytes for detection of proliferation, apoptosis, viability, and phenotype.
Cytometry Jul, 2002 | Pubmed ID: 12116360
Characterization of Treponema phagedenis-like spirochetes isolated from papillomatous digital dermatitis lesions in dairy cattle.
Journal of clinical microbiology Jun, 2003 | Pubmed ID: 12791876
Viral immunology , 2004 | Pubmed ID: 15018660
Microbiology (Reading, England) Apr, 2004 | Pubmed ID: 15073313
Immunology May, 2005 | Pubmed ID: 15819705
Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism.
Journal of biomedical materials research. Part A Mar, 2006 | Pubmed ID: 16345084
Protein stability in the presence of polymer degradation products: consequences for controlled release formulations.
Biomaterials Jun, 2006 | Pubmed ID: 16504288
Microbes and infection / Institut Pasteur May, 2006 | Pubmed ID: 16698302
Gut Jul, 2007 | Pubmed ID: 17145736
Activities of DL-alpha-difluoromethylarginine and polyamine analogues against Cryptosporidium parvum infection in a T-cell receptor alpha-deficient mouse model.
Antimicrobial agents and chemotherapy Apr, 2007 | Pubmed ID: 17242149
Cryptosporidium parvum spermidine/spermine N1-acetyltransferase exhibits different characteristics from the host enzyme.
Molecular and biochemical parasitology Apr, 2007 | Pubmed ID: 17289169
Vaccine adjuvants: current challenges and future approaches.
Journal of pharmaceutical sciences Apr, 2009 | Pubmed ID: 18704954
Polymer chemistry influences monocytic uptake of polyanhydride nanospheres.
Pharmaceutical research Mar, 2009 | Pubmed ID: 18987960
Experimental biology and medicine (Maywood, N.J.) Jun, 2009 | Pubmed ID: 19307459
Microbes and infection / Institut Pasteur Mar, 2009 | Pubmed ID: 19397886
High throughput cell-based screening of biodegradable polyanhydride libraries.
Combinatorial chemistry & high throughput screening Aug, 2009 | Pubmed ID: 19531023
The simultaneous effect of polymer chemistry and device geometry on the in vitro activation of murine dendritic cells.
Biomaterials Oct, 2009 | Pubmed ID: 19539989
Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres.
Journal of biomedical materials research. Part B, Applied biomaterials Nov, 2009 | Pubmed ID: 19642209
Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens.
Acta biomaterialia Aug, 2010 | Pubmed ID: 20123135
Experimental biology and medicine (Maywood, N.J.) Feb, 2010 | Pubmed ID: 20404038
BMC genomics , 2010 | Pubmed ID: 20929591
Experimental biology and medicine (Maywood, N.J.) Jan, 2011 | Pubmed ID: 21239734
Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases.
PloS one , 2011 | Pubmed ID: 21408610
Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.
Acta biomaterialia Jul, 2011 | Pubmed ID: 21439412
Digestive diseases and sciences Oct, 2011 | Pubmed ID: 21503679
Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants.
Biomaterials Oct, 2011 | Pubmed ID: 21703679
Mannose-functionalized "pathogen-like" polyanhydride nanoparticles target C-type lectin receptors on dendritic cells.
Molecular pharmaceutics Oct, 2011 | Pubmed ID: 21882825
The Journal of nutrition Nov, 2011 | Pubmed ID: 21918060
PloS one , 2011 | Pubmed ID: 22174891
Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.
Scientific reports , 2011 | Pubmed ID: 22355713
Tailoring the immune response by targeting C-type lectin receptors on alveolar macrophages using "pathogen-like" amphiphilic polyanhydride nanoparticles.
Biomaterials Jun, 2012 | Pubmed ID: 22465338
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유